Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > In a way...

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Feb 27, 2023 2:35pm

131 Views

Post# 35307749

RE:RE:RE:In a way...

And what would be the "right time" for such a disclosure- like materail change?

Oh right- when the material change happens.

But you keep attacking those who question, and keep helping management bury the truth. The truth they don't want shareholders to know.

P.S. Almost all presentations have Q&As for exactly the type of questions I outlined:

- What did Spectral fail to fulfill in the Infomed contract to lose control of DIMI/ SAMI?

-Why is Spectral only able to enroll Tigris at a rate 1/5 of what they've continually presented as "worst case" numbers?

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?